Germany’s Clinomic secures €23M to help doctors make faster ICU decisions: Know more
Aachen-based Clinomic, a German company providing acute and intensive care medicine, has closed a €23M Series B funding round.
Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
698 articles · Health Tech & Medtech
Aachen-based Clinomic, a German company providing acute and intensive care medicine, has closed a €23M Series B funding round.
In the rapidly evolving landscape of biotechnology and cancer research, a growing number of companies are pushing the boundaries of what is possible in oncology.
Nijmegen, the Netherlands-based QurieGen, cellular technology company, has raised €2.2M in a pre-seed funding round.
After the end of Q1 2025, it’s clear that Dutch startups are entering the year with renewed strength and momentum.
Luxembourg-based Exobiosphere, the world’s first contract research organisation dedicated to drug discovery in space, has raised €2M in a seed funding round.
Cambridge-based CMR Surgical, a company that develops surgical robotic systems for minimal access surgery, has secured over $200M (approximately €185M) in the latest financing round through a combination of equity and debt.
Leuven, Belgium-based Augustine Therapeutics NV, a biotechnology company, has secured €77.7M in an oversubscribed Series A funding round co-led by Novo Holdings and Jeito Capital.
Warsaw-based Jutro Medical, a Polish AI-first primary care provider, has raised €12M in Series A funding.
In recent years, Artificial Intelligence (AI) has advanced significantly in many areas, including healthcare.
Dublin-based Neuromod, a medtech company, announced that it has secured €10M in equity financing in a Series B funding round.
Ghent-based 4Tissue, an innovation-led research and clinical development organisation, has secured an additional €1.5M in funding.
Amsterdam-based EvidenceHunt, an AI-powered medical research platform, announced that it has secured €1.2M in a funding round led by Keen…